The store will not work correctly when cookies are disabled.
1-3-[3-(tert-butyl) phenyl]-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)]-3-phenol
ID: ALA377357
PubChem CID: 11660069
Max Phase: Preclinical
Molecular Formula: C20H24N4O
Molecular Weight: 336.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2cccc(C(C)(C)C)c2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C20H24N4O/c1-20(2,3)15-9-6-8-14(12-15)18-21-22-19(23(4)5)24(18)16-10-7-11-17(25)13-16/h6-13,25H,1-5H3
Standard InChI Key: LSXXGRSRXNOSOV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-3.5907 -18.3042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9212 -17.8120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1843 -17.0258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0134 -17.0325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2639 -17.8229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2037 -18.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1888 -19.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4672 -19.4323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7600 -19.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7790 -18.1767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5011 -17.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5871 -19.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3004 -19.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2953 -20.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5776 -20.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8635 -20.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8721 -19.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1449 -20.7589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.0466 -18.0836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.6612 -17.5362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2121 -18.8919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0743 -17.7477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3333 -18.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4917 -17.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6364 -17.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 1 0
16 17 2 0
17 12 1 0
1 12 1 0
8 9 2 0
16 18 1 0
4 5 2 0
5 19 1 0
9 10 1 0
19 20 1 0
5 1 1 0
19 21 1 0
10 11 2 0
10 22 1 0
11 6 1 0
22 23 1 0
2 6 1 0
22 24 1 0
2 3 2 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.44 | Molecular Weight (Monoisotopic): 336.1950 | AlogP: 4.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.99 | CX Basic pKa: 2.28 | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -1.26 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |